Pricing Log in Create free account

Biora Therapeutics, Inc. (BIORQ) vs Decoy Therapeutics Inc (DCOY)

Biora Therapeutics, Inc. and Decoy Therapeutics Inc are both Biotechnology companies. Biora Therapeutics, Inc. and Decoy Therapeutics Inc are of similar size ($2.7M and $2.5M). Biora Therapeutics, Inc. grew revenue faster over the last twelve months: 347.0% against −60.5%. Decoy Therapeutics Inc has the higher net margin (−698.8% vs −3,527.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Biora Therapeutics, Inc. leads on 8 and Decoy Therapeutics Inc on 7.

Valuation

Metric BIORQ DCOY Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.29 9.40
P/B n/m 0.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.49 0.66
EV/Sales 67.44 (3.49) 9.02
Earnings yield 0.00% (5,122.62%) (32.88%)
Free cash flow yield 0.00% (1,736.93%) (23.13%)

Profitability

Metric BIORQ DCOY Biotechnology median
Gross margin 85.79% 10.57% 68.51%
Operating margin (6,809.06%) (706.88%) 0.00%
Net margin (3,527.85%) (698.79%) 0.00%
Free cash flow margin (5,165.88%) (432.43%) 0.00%
Return on equity 27.98% (827.77%) (51.96%)
Return on assets (128.19%) (278.04%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BIORQ DCOY Biotechnology median
Revenue growth (TTM) 347.00% (60.49%) 6.76%
EPS growth (last fiscal year) (57.40%) 87.62% 29.88%
Revenue growth, 5-year CAGR (87.44%) 12.73% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIORQ DCOY Biotechnology median
Debt to equity (0.18) 0.00 0.00
Current ratio 0.05 1.83 4.97
Net debt to EBITDA (0.47) 0.85 1.01

Dividend

Metric BIORQ DCOY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BIORQ DCOY Biotechnology median
Market cap 2.49m 2.67m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack